Regenxbio Short Term Debt from 2010 to 2024

RGNX Stock  USD 9.58  0.01  0.10%   
Regenxbio Short Term Debt yearly trend continues to be fairly stable with very little volatility. Short Term Debt is likely to outpace its year average in 2024. During the period from 2010 to 2024, Regenxbio Short Term Debt regression line of annual values had r-squared of  0.68 and arithmetic mean of  4,440,320. View All Fundamentals
 
Short Term Debt  
First Reported
2014-12-31
Previous Quarter
39.4 M
Current Value
7.7 M
Quarterly Volatility
11.3 M
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of Regenxbio over the last few years. It is Regenxbio's Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Slightly volatile
   Short Term Debt   
       Timeline  

Regenxbio Short Term Debt Regression Statistics

Arithmetic Mean4,440,320
Geometric Mean2,594,193
Coefficient Of Variation111.36
Mean Deviation3,761,536
Median2,421,000
Standard Deviation4,944,834
Sample Variance24.5T
Range14.2M
R-Value0.83
Mean Square Error8.3T
R-Squared0.68
Significance0.0001
Slope914,581
Total Sum of Squares342.3T

Regenxbio Short Term Debt History

202414.8 M
202314.1 M
202212 M
20213.5 M
2020M
20152.4 M
20142.4 M

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Short Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term Debt14.1 M14.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.